Denali Therapeutics Inc. (DNLI) Misses Q1 EPS by 3c

Denali Therapeutics Inc. (NASDAQ: DNLI) reported Q1 EPS of ($0.69), $0.03 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Denali Therapeutics Inc. (DNLI) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Lockheed Martin wins $83 million Army missile contract
• Edgewell stock surges on report of rejected takeover bid